22-Hydroxycholesterol

22-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 22-hydroxycholesterol is associated with abnormalities such as Hypertensive disease, Cardiovascular Diseases, Congestive heart failure, Atherosclerosis and Hypercholesterolemia. The involved functions are known as physiological aspects, Regulation, Anabolism, Metabolic Inhibition and Adjudication. 22-hydroxycholesterol often locates in Body tissue, Blood, Mitochondria, Membrane and Tissue membrane. The associated genes with 22-Hydroxycholesterol are Candidate Disease Gene, ABCA1 gene, CLTC gene, SLC22A1 gene and SLC10A1 gene. The related lipids are Hydroxycholesterols, Lipopolysaccharides, 22-hydroxycholesterol, Fatty Acids and (22R)-22-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 22-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22-Hydroxycholesterol?

22-Hydroxycholesterol is suspected in Atherosclerosis, Fatty Streak, Arterial, Senile Plaques, Neurodegenerative Disorders, Coronary heart disease, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22-Hydroxycholesterol

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with 22-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22-Hydroxycholesterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 262
Authors Title Published Journal PubMed Link
Grochowski D and Szamatowicz M [The role of gonadotropins, cyclic AMP, 22-R-OH-cholesterol and cofactors in regulating endocrine functions of the Leydig cells in rats. III. Mechanisms responsible for "desensitization" of the Leydig cells of rats caused by high doses of hCG]. 1989 Ginekol. Pol. pmid:2561360
Ceroi A et al. The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. 2016 Haematologica pmid:26635040
Yoon JH et al. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis. 2004 Hepatology pmid:14999691
Gupta V Mineralocorticoid hypertension. 2011 Indian J Endocrinol Metab pmid:22145132
Patel MB et al. Liver x receptor: a novel therapeutic target. 2008 Mar-Apr Indian J Pharm Sci pmid:20046702
Cacabelos R et al. Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics. 2012 Int J Alzheimers Dis pmid:22482072
Salehipour M et al. Polyunsaturated fatty acids and modulation of cholesterol homeostasis in THP-1 macrophage-derived foam cells. 2010 Int J Mol Sci pmid:21151462
Zhao SP et al. Dual effects of oxidized low-density lipoprotein on LXR-ABCA1-apoA-I pathway in 3T3-L1 cells. 2008 Int. J. Cardiol. pmid:17643522
Norata GD et al. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. 2005 Int. J. Mol. Med. pmid:16142410
Carter CJ The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease. 2011 ISRN Neurol pmid:22389816
Noguchi N Role of oxidative stress in adaptive responses in special reference to atherogenesis. 2008 J Clin Biochem Nutr pmid:19015746
López-Velázquez JA et al. Nuclear receptors in nonalcoholic Fatty liver disease. 2012 J Lipids pmid:22187655
Kocarek TA et al. Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. 2002 May-Jun J Pharmacol Toxicol Methods pmid:12628309
Hedger MP and Eddy EM Leydig cell cooperation in vitro: evidence for communication between adult rat Leydig cells. 1990 Jan-Feb J. Androl. pmid:2155894
Meikle AW et al. Extracellular calcium and luteinizing hormone effects on 22-hydroxycholesterol used for testosterone production in mouse Leydig cells. 1991 Mar-Apr J. Androl. pmid:2050582
Wu CS et al. Melatonin inhibits the expression of steroidogenic acute regulatory protein and steroidogenesis in MA-10 cells. 2001 Mar-Apr J. Androl. pmid:11229798
Sugano S et al. Identification of intermediates in the conversion of cholesterol to pregnenolone with a reconstituted cytochrome p-450scc system: accumulation of the intermediate modulated by the adrenodoxin level. 1996 J. Biochem. pmid:8947841
Amemiya-Kudo M et al. Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c). 2011 J. Biol. Chem. pmid:21652712
Koldamova RP et al. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. 2003 J. Biol. Chem. pmid:12547833
Mast N et al. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. 2011 J. Biol. Chem. pmid:21159775
Fu X et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. 2001 J. Biol. Chem. pmid:11504730
Matsushita K et al. Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. 2010 J. Biol. Chem. pmid:20118482
Gan X et al. Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate. 2001 J. Biol. Chem. pmid:11641412
Cupp JR and Vickery LE Adrenodoxin with a COOH-terminal deletion (des 116-128) exhibits enhanced activity. 1989 J. Biol. Chem. pmid:2912975
Bowden K and Ridgway ND OSBP negatively regulates ABCA1 protein stability. 2008 J. Biol. Chem. pmid:18450749
Landis MS et al. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes. 2002 J. Biol. Chem. pmid:11741944
Denis M et al. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1). 2004 J. Biol. Chem. pmid:14660648
Agassandian M et al. Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP:phosphocholine cytidylyltransferase. 2005 J. Biol. Chem. pmid:15788406
CHAUDHURI AC et al. Biosynthesis of pregnenolone from 22-hydroxycholesterol. 1962 J. Biol. Chem. pmid:13878470
Fukumoto H et al. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. 2002 J. Biol. Chem. pmid:12384498
Kaneko E et al. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. 2003 J. Biol. Chem. pmid:12847102
Haidar B et al. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. 2004 J. Biol. Chem. pmid:14701824
Costet P et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. 2000 J. Biol. Chem. pmid:10858438
Albers M et al. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. 2006 J. Biol. Chem. pmid:16354658
Venugopal S et al. Plasma Membrane Origin of the Steroidogenic Pool of Cholesterol Used in Hormone-induced Acute Steroid Formation in Leydig Cells. 2016 J. Biol. Chem. pmid:27815506
Sparrow CP et al. A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. 2002 J. Biol. Chem. pmid:11790770
Chuu CP et al. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. 2011 J. Biomed. Sci. pmid:21859492
Huwait EA et al. Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages. 2015 J. Cell. Biochem. pmid:25752819
Shouhed D et al. Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells. 2005 J. Cell. Biochem. pmid:15880703
Jabara S et al. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. 2003 J. Clin. Endocrinol. Metab. pmid:12519894
Sokalska A et al. Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability. 2010 J. Clin. Endocrinol. Metab. pmid:20826585
Escobar JC et al. The human placenta expresses CYP17 and generates androgens de novo. 2011 J. Clin. Endocrinol. Metab. pmid:21307141
Honjo Y et al. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. 2006 J. Endocrinol. pmid:16522742
Lin T et al. Interleukin-1 inhibits Leydig cell steroidogenesis without affecting steroidogenic acute regulatory protein messenger ribonucleic acid or protein levels. 1998 J. Endocrinol. pmid:9582502
Ragoobir J et al. Stimulation of progesterone production in human granulosa-lutein cells by lipoproteins: evidence for cholesterol-independent actions of high-density lipoproteins. 2002 J. Endocrinol. pmid:11927389
Joo SH et al. Biosynthesis of a cholesterol-derived brassinosteroid, 28-norcastasterone, in Arabidopsis thaliana. 2012 J. Exp. Bot. pmid:22170941
Raccosta L et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. 2013 J. Exp. Med. pmid:23897983
Kömüves LG et al. Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. 2002 J. Invest. Dermatol. pmid:11851872
Fowler AJ et al. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. 2003 J. Invest. Dermatol. pmid:12542530
Hong I et al. LXRalpha enhances lipid synthesis in SZ95 sebocytes. 2008 J. Invest. Dermatol. pmid:17960176